This is a serious illness that affects many parts of your body. It's caused by a chemical called L-tryptophan. Symptoms include muscle pain, skin rashes, and problems with your heart, lungs, and blood vessels. It's a complex condition that needs careful medical attention.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Eosinophilia-Myalgia Syndrome?
Eosinophilia-myalgia syndrome (EMS) is a rare inflammatory illness linked to supplements containing L-tryptophan, an amino acid sold to help with sleep and mood. Its name describes its two hallmarks: eosinophilia, a high level of eosinophils (a type of white blood cell involved in allergy and inflammation) in the blood, and myalgia, or muscle pain. The pain is often severe enough to make walking or ordinary daily tasks difficult. EMS can affect many parts of the body at once, including the muscles, skin, nerves, lungs and heart. It usually starts fairly quickly, with muscle aches and cramps, fatigue, shortness of breath or cough, swelling, joint pain, fever, tingling and an itchy rash. Over the following months some people develop thickened, hardened skin, especially on the arms and legs, along with nerve damage and muscle weakness. The condition became known during a 1989 outbreak in the United States, when more than 1,500 cases and dozens of deaths were reported before contaminated supplements were recalled. New cases have been rare since then.
Nearly all cases from the 1989 outbreak were traced to L-tryptophan made by a single manufacturer. The evidence points to a contaminant created during production rather than tryptophan itself, which is a normal part of the diet. Researchers have studied several impurities but still have not settled which one caused the illness or exactly how. In the outbreak, people who took more of the contaminated product were more likely to become ill. Since the outbreak, occasional cases have been reported in people taking L-tryptophan or 5-HTP (5-hydroxytryptophan, a closely related supplement sold for mood, sleep and weight loss). Dietary supplements in the United States are regulated more loosely than prescription medicines, so the purity of a product can be hard to judge from its label. It is not known why some exposed people became ill while others taking the same product did not.
No single test confirms EMS. A clinician looks for the combination that defines it: a high eosinophil count, severe muscle pain, and recent use of an L-tryptophan or 5-HTP supplement, after ruling out infections, cancers and other conditions that raise eosinophils. A careful supplement history matters, including sleep aids, bodybuilding products and weight-loss products that may contain these ingredients. During the outbreak, health officials counted a case when the blood had at least 1,000 eosinophils per cubic millimeter alongside muscle pain severe enough to limit daily activities. That definition was built for tracking an epidemic, not for individual care. Someone with a lower count or milder pain can still have EMS, and some people who never took tryptophan meet those numbers for other reasons. Blood tests may also show signs of muscle damage, such as a raised aldolase level, or abnormal liver tests. A biopsy of affected skin, fascia (the tissue layer beneath the skin) or muscle can show the pattern of inflammation and help separate EMS from look-alike conditions such as eosinophilic fasciitis, scleroderma and other eosinophil disorders. Nerve, lung and heart testing are used when symptoms point to those organs.
The first step is stopping any L-tryptophan or 5-HTP product. There is no proven treatment beyond that and no formal guideline, so care is shaped around the organs involved and the symptoms causing the most trouble. Corticosteroids such as prednisone are often used to calm inflammation and may ease swelling and some symptoms, but studies of people from the outbreak did not find that they shortened the illness or improved long-term outcomes, and long courses carry their own side effects. When skin and fascia thickening persists, specialists sometimes add other medicines that suppress the immune system, an approach borrowed from eosinophilic fasciitis. Much of the work is supportive: pain relief, muscle relaxants for cramps, diuretics (water pills) for fluid swelling, and physical therapy to protect strength and joint movement. During the intense early phase people may need to limit strenuous activity, and some need a hospital stay. Care often involves a rheumatologist along with neurology, lung, heart or skin specialists as needed.
EMS usually has two phases. The early, acute phase of muscle pain, cramps, swelling and breathlessness tends to last several months. After that, many people settle into a longer phase in which symptoms come and go, and in which skin thickening, nerve symptoms, muscle weakness and deep fatigue can become the main problems. The outlook varies widely. Some people recover fully, and most in follow-up studies of the outbreak said they were better than at their worst. Even so, many still reported fatigue, weakness, cramps, joint pain or tight skin years later, and for a substantial share EMS became a chronic illness that changed work and daily routines. Some people also report trouble with memory and concentration; researchers disagree about whether this comes from the disease itself or from pain, poor sleep and low mood. Staying as physically active as symptoms allow appears to help in the longer phase. Regular follow-up lets the care team watch for nerve, lung and heart changes and adjust pain, sleep and rehabilitation support. Because EMS is rare and can resemble fibromyalgia, chronic fatigue syndrome or lupus, keeping records of the original diagnosis and supplement exposure helps future clinicians.
See a clinician if you develop new, persistent muscle pain, cramps, swelling, rash or unusual fatigue while taking or soon after taking L-tryptophan or 5-HTP, and stop the product while you are evaluated. Bring the product or its label to the visit. If you have EMS, get urgent medical care the same day for weakness that is spreading or worsening quickly, new or increasing shortness of breath, chest pain, or a racing or irregular heartbeat. Progressive nerve and muscle weakness, lung disease and heart involvement caused most of the serious harm in the 1989 outbreak. Severe difficulty breathing needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Eosinophilia-Myalgia Syndrome is like, what's helped you, or ask the community a question.